The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series
Movement Disorders · 2023
DOI: 10.1002/mds.29328 ↗Kurz gefasst
Leserbrief in der Zeitschrift Movement Disorders, 2023. Verfasst von Xin-Yi Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Med…. Hauptthemen laut MEDLINE: Selegiline, Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Nuclear Medicine & PET Center, National Center for Neurological Disorders, and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
- APRINOIA Therapeutics, Suzhou, China.
ORCID-Profile: Xin-Yi Li, Gen Li, Chuantao Zuo, Jian Wang, Jia-Ying Lu, Feng-Tao Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X. Y., Jiao, F. Y., Yao, R. X., Ju, Z. Z., Chen, M. J., Ge, J. J., Li, G., Sun, Y. M., Wu, P., Wu, J. J., Yen, T. C., Zuo, C., Wang, J., Lu, J. Y., Liu, F. T., & Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI) (2023). The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series. Movement Disorders. https://doi.org/10.1002/mds.29328
Vancouver
Li XY, Jiao FY, Yao RX, Ju ZZ, Chen MJ, Ge JJ, et al. The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series. Movement Disorders. 2023. doi:10.1002/mds.29328
BibTeX
@article{Li2023,
author = {Li, Xin-Yi and Jiao, Fang-Yang and Yao, Rui-Xin and Ju, Zi-Zhao and Chen, Ming-Jia and Ge, Jing-Jie and Li, Gen and Sun, Yi-Min and Wu, Ping and Wu, Jian-Jun and Yen, Tzu-Chen and Zuo, Chuantao and Wang, Jian and Lu, Jia-Ying and Liu, Feng-Tao and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI), Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)},
title = {The Monoamine Oxidase‐B Inhibitor Selegiline Does Not Affect 18 F‐Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29328}
}
EUVIMED